在临床试验中生成合成控制的贝叶斯非参数常见原子回归
Noirrit Kiran Chandra1, Abhra Sarkar2, John F de Groot3
1Department of Mathematical Sciences, The University of Texas at Dallas, Richardson, TX.
Journal of the American Statistical Association
|March 9, 2026
概括
电子健康记录 (EHR) 可以为临床试验创建合成控制臂. 这种新的贝叶斯模型改进了治疗效应检测,特别是非线性反应,使用现实世界的数据.
科学领域:
- 生物统计学 生物统计学
- 医疗信息学 医疗信息学
- 临床试验设计 临床试验设计
背景情况:
- 随机对照试验 (RCT) 既昂贵又具有挑战性.
- 电子健康记录 (EHR) 提供了宝贵的现实数据来源.
- 以现实世界的证据来补充传统试验越来越重要.
研究的目的:
- 开发一种方法来构建合成控制臂,使用EHR数据进行单臂试验.
- 为此目的提出一种新的非参数贝叶斯常见原子混合模型.
- 为了使治疗效应的可靠推断使用现实世界的数据.
主要方法:
- 利用EHR数据来识别与治疗组相比相当的患者层.
- 采用一个非参数的贝叶斯常见原子混合模型.
- 实施了数据重新抽样的无密度重要性抽样计划.
- 用于单臂试验的合成控制臂.
主要成果:
- 与替代方法相比,拟议的方法在检测治疗效应方面表现出更高的统计能力.
- 对非线性响应函数的有效性尤其显著.
- 该方法已成功应用于使用历史试验数据的质母细胞瘤研究.
结论:
- 新的贝叶斯方法有效地从EHR数据生成合成控制臂.
- 这种方法提高了单臂试验中治疗效应推断的强度.
- 它为传统的RCT提供了成本效益和效率的替代方案,特别是在瘤学中.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
515
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
515
Controls in Experiments
18.7K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
18.7K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
347
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
347
Randomized Experiments
9.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
9.2K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
382
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
382
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
301
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
301


